XML 78 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidating Financial Statements
12 Months Ended
Dec. 31, 2019
Condensed Financial Information Disclosure [Abstract]  
Consolidating Financial Statements Consolidating financial statements
The following information is presented in accordance with Rule 3-10 of Regulation S-X. The operating and investing activities of the separate legal entities included in the Company’s consolidated financial statements are fully interdependent and integrated. Revenues and operating expenses of the separate legal entities include intercompany charges for management and other administrative services. The Company’s senior notes are guaranteed by a substantial majority of its domestic subsidiaries as measured by revenue, income and assets. The subsidiary guarantors have guaranteed the senior notes on a joint and several basis. However, a subsidiary guarantor will be released from its obligations under its guarantee of the senior notes and the indentures governing the senior notes if, in general, there is a sale or other disposition of all or substantially all of the assets of such subsidiary guarantor, including by merger or consolidation, or a sale or other disposition of all of the equity interests in such subsidiary guarantor held by the Company and its restricted subsidiaries, as defined in the indentures; such subsidiary guarantor is designated by the Company as an unrestricted subsidiary, as defined in the indentures, or otherwise ceases to be a restricted subsidiary of the Company, in each case in accordance with the indentures; or such subsidiary guarantor no longer guarantees any other indebtedness, as defined in the indentures, of the Company or any of its restricted subsidiaries, except for guarantees that are contemporaneously released. The senior notes are not guaranteed by certain of the Company's domestic subsidiaries, any of the Company's foreign subsidiaries, or any entities that do not constitute subsidiaries within the meaning of the indentures, such as corporations in which the Company holds capital stock with less than a majority of the voting power, joint ventures and partnerships in which the Company holds less than a majority of the equity or voting interests, non-owned entities and third parties. Contemporaneously with the Company entering into the New Credit Agreement and pursuant to the indentures governing the Company's senior notes, certain subsidiaries of the Company were released from their guarantees of the Company's senior notes such that, after that release, the remaining subsidiary guarantors of the senior notes were the same subsidiaries guaranteeing the New Credit Agreement. The following consolidating statements have been prepared for all periods presented based on the current subsidiary guarantors and non-guarantors stipulated in the Company's New Credit Agreement.
Consolidating Statements of Income
For year ended December 31, 2019
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Dialysis patient service revenues
 
$

 
$
6,961,825

 
$
4,226,402

 
$
(269,806
)
 
$
10,918,421

Less: Provision for uncollectible accounts
 

 
(15,296
)
 
(6,419
)
 

 
(21,715
)
Net dialysis patient service revenues
 

 
6,946,529

 
4,219,983

 
(269,806
)
 
10,896,706

Other revenues
 
804,684

 
601,394

 
171,856

 
(1,086,161
)
 
491,773

Total revenues
 
804,684

 
7,547,923

 
4,391,839

 
(1,355,967
)
 
11,388,479

Operating expenses and charges
 
642,717

 
6,631,471

 
3,826,941

 
(1,355,967
)
 
9,745,162

Operating income
 
161,967

 
916,452

 
564,898

 

 
1,643,317

Debt expense
 
(482,074
)
 
(183,272
)
 
(53,043
)
 
241,163

 
(477,226
)
Other income, net
 
309,623

 
7,314

 
46,306

 
(333,895
)
 
29,348

Income tax (benefit) expense
 
(2,616
)
 
263,563

 
18,681

 

 
279,628

Equity earnings in subsidiaries
 
818,849

 
429,628

 

 
(1,248,477
)
 

Net income from continuing operations
 
810,981

 
906,559

 
539,480

 
(1,341,209
)
 
915,811

Net income from discontinued operations, net of tax
 

 

 
12,751

 
92,732

 
105,483

Net income
 
810,981

 
906,559

 
552,231

 
(1,248,477
)
 
1,021,294

Less: Net income attributable to noncontrolling
interests
 

 

 

 
(210,313
)
 
(210,313
)
Net income attributable to DaVita Inc.
 
$
810,981

 
$
906,559

 
$
552,231

 
$
(1,458,790
)
 
$
810,981


Consolidating Statements of Income - (continued)
For year ended December 31, 2018
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Dialysis patient service revenues
 
$

 
$
6,834,865

 
$
4,096,666

 
$
(221,550
)
 
$
10,709,981

Less: Provision for uncollectible accounts
 

 
(34,977
)
 
(14,610
)
 

 
(49,587
)
Net dialysis patient service revenues
 

 
6,799,888

 
4,082,056

 
(221,550
)
 
10,660,394

Other revenues
 
799,230

 
488,086

 
558,079

 
(1,100,938
)
 
744,457

Total revenues
 
799,230

 
7,287,974

 
4,640,135

 
(1,322,488
)
 
11,404,851

Operating expenses and charges
 
646,640

 
6,551,328

 
4,003,547

 
(1,322,488
)
 
9,879,027

Operating income
 
152,590

 
736,646

 
636,588

 

 
1,525,824

Debt expense
 
(491,749
)
 
(201,496
)
 
(43,414
)
 
249,224

 
(487,435
)
Other income, net
 
418,839

 
3,430

 
29,132

 
(441,312
)
 
10,089

Income tax expense
 
23,482

 
155,372

 
79,546

 

 
258,400

Equity earnings in subsidiaries
 
103,196

 
388,737

 

 
(491,933
)
 

Net income from continuing operations
 
159,394

 
771,945

 
542,760

 
(684,021
)
 
790,078

Net loss from discontinued operations, net of tax
 

 

 
(649,126
)
 
192,088

 
(457,038
)
Net income (loss)
 
159,394

 
771,945

 
(106,366
)
 
(491,933
)
 
333,040

Less: Net income attributable to noncontrolling
interests
 

 

 

 
(173,646
)
 
(173,646
)
Net income (loss) attributable to DaVita Inc.
 
$
159,394

 
$
771,945

 
$
(106,366
)
 
$
(665,579
)
 
$
159,394

 
For year ended December 31, 2017
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Dialysis patient service revenues
 
$

 
$
6,417,574

 
$
3,848,172

 
$
(172,076
)
 
$
10,093,670

Less: Provision for uncollectible accounts
 

 
(322,085
)
 
(170,447
)
 
7,168

 
(485,364
)
Net dialysis patient service
revenues
 

 
6,095,489

 
3,677,725

 
(164,908
)
 
9,608,306

Other revenues
 
793,751

 
408,460

 
1,080,832

 
(1,014,715
)
 
1,268,328

Total net revenues
 
793,751

 
6,503,949

 
4,758,557

 
(1,179,623
)
 
10,876,634

Operating expenses and charges
 
527,942

 
5,331,545

 
4,384,015

 
(1,179,623
)
 
9,063,879

Operating income
 
265,809

 
1,172,404

 
374,542

 

 
1,812,755

Debt expense
 
(426,149
)
 
(200,953
)
 
(43,490
)
 
239,958

 
(430,634
)
Other income, net
 
411,731

 
5,979

 
23,657

 
(423,702
)
 
17,665

Income tax expense
 
65,965

 
210,068

 
47,826

 

 
323,859

Equity earnings in subsidiaries
 
478,192

 
460,261

 

 
(938,453
)
 

Net income from continuing operations
 
663,618

 
1,227,623

 
306,883

 
(1,122,197
)
 
1,075,927

Net loss from discontinued operations, net of tax
 

 

 
(429,116
)
 
183,744

 
(245,372
)
Net income (loss)
 
663,618

 
1,227,623

 
(122,233
)
 
(938,453
)
 
830,555

Less: Net income attributable to noncontrolling
interests
 

 

 

 
(166,937
)
 
(166,937
)
Net income (loss) attributable to DaVita Inc.
 
$
663,618

 
$
1,227,623

 
$
(122,233
)
 
$
(1,105,390
)
 
$
663,618


 
Consolidating Statements of Comprehensive Income
For the year ended December 31, 2019
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Net income
 
$
810,981

 
$
906,559

 
$
552,231

 
$
(1,248,477
)
 
$
1,021,294

Other comprehensive income (loss)
 
7,528

 

 
(20,102
)
 

 
(12,574
)
Total comprehensive income
 
818,509

 
906,559

 
532,129

 
(1,248,477
)
 
1,008,720

Less: Comprehensive income attributable to
noncontrolling interest
 

 

 

 
(210,313
)
 
(210,313
)
Comprehensive income attributable to DaVita Inc.
 
$
818,509

 
$
906,559

 
$
532,129

 
$
(1,458,790
)
 
$
798,407

 
 
 
 
 
 
 
 
 
 
 
For the year ended December 31, 2018
 
 

 
 

 
 

 
 

 
 

Net income (loss)
 
$
159,394

 
$
771,945

 
$
(106,366
)
 
$
(491,933
)
 
$
333,040

Other comprehensive income (loss)
 
6,153

 

 
(45,944
)
 

 
(39,791
)
Total comprehensive income (loss)
 
165,547

 
771,945

 
(152,310
)
 
(491,933
)
 
293,249

Less: Comprehensive income attributable to
noncontrolling interest
 

 

 

 
(173,646
)
 
(173,646
)
Comprehensive income (loss) attributable to DaVita Inc.
 
$
165,547

 
$
771,945

 
$
(152,310
)
 
$
(665,579
)
 
$
119,603

 
 
 
 
 
 
 
 
 
 
 
For the year ended December 31, 2017
 
 

 
 

 
 

 
 

 
 

Net income (loss)
 
$
663,618

 
$
1,227,623

 
$
(122,233
)
 
$
(938,453
)
 
$
830,555

Other comprehensive income (loss)
 
3,106

 

 
99,770

 

 
102,876

Total comprehensive income (loss)
 
666,724

 
1,227,623

 
(22,463
)
 
(938,453
)
 
933,431

Less: Comprehensive income attributable to
noncontrolling interest
 

 

 

 
(166,935
)
 
(166,935
)
Comprehensive income (loss) attributable to DaVita Inc.
 
$
666,724

 
$
1,227,623

 
$
(22,463
)
 
$
(1,105,388
)
 
$
766,496


 
Consolidating Balance Sheets
As of December 31, 2019
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Cash and cash equivalents
 
$
758,241

 
$
532

 
$
343,599

 
$

 
$
1,102,372

Restricted cash and equivalents
 
14,499

 

 
91,847

 

 
106,346

Accounts receivable, net
 

 
1,189,301

 
606,297

 

 
1,795,598

Other current assets
 
76,787

 
548,553

 
102,410

 
(41,896
)
 
685,854

Total current assets
 
849,527

 
1,738,386

 
1,144,153

 
(41,896
)
 
3,690,170

Property and equipment, net
 
543,932

 
1,589,417

 
1,344,543

 
(4,508
)
 
3,473,384

Operating lease right-of-use assets
 
109,415

 
1,656,145

 
1,084,552

 
(20,065
)
 
2,830,047

Intangible assets, net
 
362

 
31,569

 
103,753

 

 
135,684

Investments in and advances to affiliates, net
 
10,813,991

 
7,611,402

 
3,051,208

 
(21,476,601
)
 

Other long-term assets and investments
 
102,779

 
133,698

 
176,315

 
(18,318
)
 
394,474

Goodwill
 

 
4,812,972

 
1,974,663

 

 
6,787,635

Total assets
 
$
12,420,006

 
$
17,573,589

 
$
8,879,187

 
$
(21,561,388
)
 
$
17,311,394

Current liabilities
 
$
379,286

 
$
1,327,378

 
$
666,470

 
$
(1,036
)
 
$
2,372,098

Intercompany payables
 
1,381,863

 
3,051,208

 
2,615,151

 
(7,048,222
)
 

Long-term operating lease liabilities
 
136,123

 
1,567,776

 
1,039,145

 
(19,244
)
 
2,723,800

Long-term debt and other long-term liabilities
 
7,741,725

 
674,558

 
364,102

 
(64,507
)
 
8,715,878

Noncontrolling interests subject to put provisions
 
647,600

 

 

 
532,776

 
1,180,376

Total DaVita Inc. shareholders' equity
 
2,133,409

 
10,952,669

 
3,475,710

 
(14,428,379
)
 
2,133,409

Noncontrolling interests not subject to put
provisions
 

 

 
718,609

 
(532,776
)
 
185,833

Total equity
 
2,133,409

 
10,952,669

 
4,194,319

 
(14,961,155
)
 
2,319,242

Total liabilities and equity
 
$
12,420,006

 
$
17,573,589

 
$
8,879,187

 
$
(21,561,388
)
 
$
17,311,394


Consolidating Balance Sheets - (continued)
As of December 31, 2018
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-
Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Cash and cash equivalents
 
$
60,653

 
$
1,232

 
$
261,153

 
$

 
$
323,038

Restricted cash and equivalents
 
1,005

 
12,048

 
79,329

 

 
92,382

Accounts receivable, net
 

 
1,204,122

 
654,486

 

 
1,858,608

Other current assets
 
37,185

 
565,974

 
157,407

 

 
760,566

Current assets held for sale
 

 

 
5,389,565

 

 
5,389,565

Total current assets
 
98,843

 
1,783,376

 
6,541,940

 

 
8,424,159

Property and equipment, net
 
491,462

 
1,584,321

 
1,317,886

 

 
3,393,669

Intangible assets, net
 
153

 
42,896

 
75,797

 

 
118,846

Investments in and advances to affiliates, net
 
13,522,198

 
6,196,801

 
2,498,545

 
(22,217,544
)
 

Other long-term assets and investments
 
53,385

 
90,037

 
188,196

 

 
331,618

Goodwill
 

 
4,806,939

 
2,035,021

 

 
6,841,960

Total assets
 
$
14,166,041

 
$
14,504,370

 
$
12,657,385

 
$
(22,217,544
)
 
$
19,110,252

Current liabilities
 
$
1,945,943

 
$
1,217,526

 
$
483,933

 
$

 
$
3,647,402

Current liabilities held for sale
 

 

 
1,243,759

 

 
1,243,759

Total current liabilities
 
1,945,943

 
1,217,526

 
1,727,692

 

 
4,891,161

Intercompany payables
 

 
2,498,545

 
6,161,292

 
(8,659,837
)
 

Long-term debt and other long-term liabilities
 
7,918,581

 
687,443

 
580,028

 

 
9,186,052

Noncontrolling interests subject to put provisions
 
598,075

 

 

 
526,566

 
1,124,641

Total DaVita Inc. shareholders' equity
 
3,703,442

 
10,100,856

 
3,456,851

 
(13,557,707
)
 
3,703,442

Noncontrolling interests not subject to put
provisions
 

 

 
731,522

 
(526,566
)
 
204,956

Total equity
 
3,703,442

 
10,100,856

 
4,188,373

 
(14,084,273
)
 
3,908,398

Total liabilities and equity
 
$
14,166,041

 
$
14,504,370

 
$
12,657,385

 
$
(22,217,544
)
 
$
19,110,252





 
Consolidating Statements of Cash Flow 
For the year ended December 31, 2019
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Cash flows from operating activities:
 
 

 
 

 
 

 
 

 
 

Net income
 
$
810,981

 
$
906,559

 
$
552,231

 
$
(1,248,477
)
 
$
1,021,294

Changes in operating assets and liabilities and
non-cash items included in net income
 
(602,288
)
 
(73,356
)
 
478,228

 
1,248,477

 
1,051,061

Net cash provided by operating activities
 
208,693

 
833,203

 
1,030,459

 

 
2,072,355

Cash flows from investing activities:
 
 

 
 

 
 

 
 

 
 

Additions of property and equipment, net
 
(145,378
)
 
(310,032
)
 
(311,136
)
 

 
(766,546
)
Acquisitions
 

 
(11,851
)
 
(89,010
)
 

 
(100,861
)
Proceeds from asset sales, net of cash divested
 
3,824,516

 
1,777

 
51,099

 

 
3,877,392

Investments and other items
 
(4,606
)
 
(6,676
)
 
(3,363
)
 

 
(14,645
)
Net cash provided by (used in) investing activities
 
3,674,532

 
(326,782
)
 
(352,410
)
 

 
2,995,340

Cash flows from financing activities:
 
 

 
 

 
 

 
 

 
 

Long-term debt and related financing costs, net
 
(2,052,197
)
 
(10,481
)
 
(17,513
)
 

 
(2,080,191
)
Intercompany borrowing
 
1,267,138

 
(455,405
)
 
(811,733
)
 

 

Other items
 
(2,387,084
)
 
(53,283
)
 
(175,892
)
 

 
(2,616,259
)
Net cash used in financing activities
 
(3,172,143
)
 
(519,169
)
 
(1,005,138
)
 

 
(4,696,450
)
Effect of exchange rate changes on cash
 

 

 
(1,760
)
 

 
(1,760
)
Net increase (decrease) in cash, cash equivalents and restricted cash
 
711,082

 
(12,748
)
 
(328,849
)
 

 
369,485

Less: Net increase in cash, cash equivalents and
restricted cash from discontinued operations
 

 

 
(423,813
)
 

 
(423,813
)
Net increase (decrease) in cash, cash equivalents and restricted cash from continuing operations
 
711,082

 
(12,748
)
 
94,964

 

 
793,298

Cash, cash equivalents and restricted cash of
continuing operations at beginning of the year
 
61,658

 
13,280

 
340,482

 

 
415,420

Cash, cash equivalents and restricted cash of
continuing operations at end of the year
 
$
772,740

 
$
532

 
$
435,446

 
$

 
$
1,208,718




















Consolidating Statements of Cash Flow - (continued)
For the year ended December 31, 2018
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
Net income
 
$
159,394

 
$
771,945

 
$
(106,366
)
 
$
(491,933
)
 
$
333,040

Changes in operating assets and liabilities and
non-cash items included in net income
 
(86,070
)
 
(150,976
)
 
1,183,713

 
491,933

 
1,438,600

Net cash provided by operating activities
 
73,324

 
620,969

 
1,077,347

 

 
1,771,640

Cash flows from investing activities:
 
 

 
 

 
 

 
 

 
 

Additions of property and equipment, net
 
(175,787
)
 
(425,008
)
 
(386,343
)
 

 
(987,138
)
Acquisitions
 

 
(42,987
)
 
(140,169
)
 

 
(183,156
)
Proceeds from asset and business sales, net of cash
divested
 

 
55,184

 
95,021

 

 
150,205

Investments and other items
 
30,962

 
(8,286
)
 
(8,230
)
 

 
14,446

Net cash used in investing activities
 
(144,825
)
 
(421,097
)
 
(439,721
)
 

 
(1,005,643
)
Cash flows from financing activities:
 
 

 
 

 
 

 
 

 
 

Long-term debt and related financing costs, net
 
725,889

 
(8,874
)
 
(22,238
)
 

 
694,777

Intercompany borrowing
 
404,897

 
(168,224
)
 
(236,673
)
 

 

Other items
 
(1,147,934
)
 
(29,457
)
 
(142,740
)
 

 
(1,320,131
)
Net cash used in financing activities
 
(17,148
)
 
(206,555
)
 
(401,651
)
 

 
(625,354
)
Effect of exchange rate changes on cash
 

 

 
(3,350
)
 

 
(3,350
)
Net (decrease) increase in cash, cash equivalents and restricted cash
 
(88,649
)
 
(6,683
)
 
232,625

 

 
137,293

Less: Net decrease in cash, cash equivalents
and restricted cash from discontinued operations
 

 

 
240,793

 

 
240,793

Net decrease in cash, cash equivalents and restricted cash from continuing operations
 
(88,649
)
 
(6,683
)
 
(8,168
)
 

 
(103,500
)
Cash, cash equivalents and restricted cash of
continuing operations at beginning of the year
 
150,307

 
19,963

 
348,650

 

 
518,920

Cash, cash equivalents and restricted cash of
continuing operations at end of the year
 
$
61,658

 
$
13,280

 
$
340,482

 
$

 
$
415,420

Consolidating Statements of Cash Flow - (continued)
For the year ended December 31, 2017
 
DaVita Inc.
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Consolidating
Adjustments
 
Consolidated
Total
Cash flows from operating activities:
 
 

 
 

 
 

 
 

 
 

Net income
 
$
663,618

 
$
1,227,623

 
$
(122,233
)
 
$
(938,453
)
 
$
830,555

Changes in operating assets and liabilities and
non-cash items included in net income
 
(533,300
)
 
(739,023
)
 
1,416,481

 
938,453

 
1,082,611

Net cash provided by operating activities
 
130,318

 
488,600

 
1,294,248

 

 
1,913,166

Cash flows from investing activities:
 
 

 
 

 
 

 
 

 
 

Additions of property and equipment, net
 
(155,972
)
 
(348,292
)
 
(400,986
)
 

 
(905,250
)
Acquisitions
 

 
(528,588
)
 
(275,291
)
 

 
(803,879
)
Proceeds from asset sales
 

 
25,989

 
66,347

 

 
92,336

Investments and other items
 
211,619

 
(3,526
)
 
43,968

 

 
252,061

Net cash provided by (used in) investing activities
 
55,647

 
(854,417
)
 
(565,962
)
 

 
(1,364,732
)
Cash flows from financing activities:
 
 

 
 

 
 

 
 

 
 

Long-term debt and related financing costs, net
 
173,529

 
(8,186
)
 
(10,495
)
 

 
154,848

Intercompany borrowing
 
22,589

 
382,452

 
(405,041
)
 

 

Other items
 
(781,697
)
 
(2,205
)
 
(137,203
)
 

 
(921,105
)
Net cash (used in) provided by financing activities
 
(585,579
)
 
372,061

 
(552,739
)
 

 
(766,257
)
Effect of exchange rate changes on cash
 

 

 
254

 

 
254

Net (decrease) increase in cash, cash equivalents and restricted cash
 
(399,614
)
 
6,244

 
175,801

 

 
(217,569
)
Less: Net decrease in cash, cash equivalents and restricted cash from discontinued operations
 

 

 
(53,026
)
 

 
(53,026
)
Net (decrease) increase in cash, cash equivalents and restricted cash from continuing operations
 
(399,614
)
 
6,244

 
228,827

 

 
(164,543
)
Cash, cash equivalents and restricted cash of
continuing operations at beginning of the year
 
549,921

 
13,719

 
119,823

 

 
683,463

Cash, cash equivalents and restricted cash of
continuing operations at end of the year
 
$
150,307

 
$
19,963

 
$
348,650

 
$

 
$
518,920